Compare IPGP & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IPGP | GPCR |
|---|---|---|
| Founded | 1990 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.3B |
| IPO Year | 2000 | 2023 |
| Metric | IPGP | GPCR |
|---|---|---|
| Price | $120.73 | $58.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $122.17 | $104.64 |
| AVG Volume (30 Days) | 715.8K | ★ 770.4K |
| Earning Date | 05-14-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 117.85 | N/A |
| EPS | ★ 0.73 | N/A |
| Revenue | ★ $1,003,777,000.00 | N/A |
| Revenue This Year | $7.39 | N/A |
| Revenue Next Year | $11.50 | N/A |
| P/E Ratio | $173.88 | ★ N/A |
| Revenue Growth | ★ 2.73 | N/A |
| 52 Week Low | $48.59 | $13.24 |
| 52 Week High | $155.82 | $94.90 |
| Indicator | IPGP | GPCR |
|---|---|---|
| Relative Strength Index (RSI) | 50.31 | 27.01 |
| Support Level | $73.73 | $18.36 |
| Resistance Level | $141.43 | $93.91 |
| Average True Range (ATR) | 9.77 | 3.19 |
| MACD | -2.86 | -1.03 |
| Stochastic Oscillator | 0.71 | 7.02 |
IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, laser and non-laser systems, fiber amplifiers, diode lasers, and related optical components. Its products are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company sells its products globally to original equipment manufacturers (OEMs), system integrators, and end users. Additionally, it manufactures complementary products used with its lasers, including optical delivery cables, fiber couplers, beam switches, optical processing heads, in-line sensors, and chillers. Geographically, the company generates maximum revenue from North America, followed by China, Japan, Germany, and other markets.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.